1. Home
  2. SNFCA vs LRMR Comparison

SNFCA vs LRMR Comparison

Compare SNFCA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$8.54

Market Cap

233.9M

Sector

Finance

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$4.80

Market Cap

280.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNFCA
LRMR
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
280.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SNFCA
LRMR
Price
$8.54
$4.80
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.29
AVG Volume (30 Days)
28.3K
6.6M
Earning Date
01-01-0001
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
73.44
N/A
EPS
0.73
N/A
Revenue
$334,522,668.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.88
N/A
Revenue Growth
5.03
N/A
52 Week Low
$7.69
$1.61
52 Week High
$12.98
$6.42

Technical Indicators

Market Signals
Indicator
SNFCA
LRMR
Relative Strength Index (RSI) 38.59 49.32
Support Level $8.44 $3.33
Resistance Level $9.34 $5.37
Average True Range (ATR) 0.26 0.64
MACD -0.07 -0.05
Stochastic Oscillator 5.42 32.23

Price Performance

Historical Comparison
SNFCA
LRMR

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: